Literature DB >> 10425965

TMD in patients with primary Sjögren syndrome: a comparison with temporomandibular clinic cases and controls.

T List1, B Stenström, I Lundström, S F Dworkin.   

Abstract

AIMS: The aim of this study was to investigate the prevalence of temporomandibular disorders (TMD) in patients with primary Sjögren syndrome (1 degree SS), analyze the impact of the disease on mandibular function, and assess psychosocial distress.
METHODS: Sixty-three subjects, 60 women and 3 men, participated in the study; 21 1 degree SS patients were compared with age-matched and gender-matched groups of TMD subjects and controls. Patients were examined according to the Research Diagnostic Criteria for Temporomandibular Disorders.
RESULTS: Results showed that the subjective, clinical, and radiographic signs of TMD are not more common in patients with 1 degree SS than in controls. The impact of the autoimmune disease on mandibular function, e.g., speech and chewing ability, revealed limitations in oral functioning similar to those in patients with TMD pain.
CONCLUSION: Both 1 degree SS and chronic TMD may be associated with appreciable physical discomfort and psychosocial dysfunction. However, the underlying mechanisms of the oral dysfunction of 1 degree SS and TMD are quite different and essentially unrelated.

Entities:  

Mesh:

Year:  1999        PMID: 10425965

Source DB:  PubMed          Journal:  J Orofac Pain        ISSN: 1064-6655


  2 in total

Review 1.  Factors involved in the etiology of temporomandibular disorders - a literature review.

Authors:  Andrea Maria Chisnoiu; Alina Monica Picos; Sever Popa; Petre Daniel Chisnoiu; Liana Lascu; Andrei Picos; Radu Chisnoiu
Journal:  Clujul Med       Date:  2015-11-15

2.  Orofacial Manifestations and Temporomandibular Disorders of Sjögren Syndrome: An Observational Study.

Authors:  Vito Crincoli; Mariasevera Di Comite; Mariateresa Guerrieri; Rossana Patricia Rotolo; Luisa Limongelli; Angela Tempesta; Florenzo Iannone; Angela Rinaldi; Giovanni Lapadula; Gianfranco Favia
Journal:  Int J Med Sci       Date:  2018-03-08       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.